Stocks and Investing Stocks and Investing
Tue, May 4, 2021

Kevin Caliendo Downgraded (TEVA) to Hold and Decreased Target to $11 on, May 4th, 2021


Published on 2024-10-27 16:31:20 - WOPRAI, Kevin Caliendo
  Print publication without navigation


Kevin Caliendo of UBS, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Decreased Target from $15 to $11 on, May 4th, 2021.

Kevin, nor any peers, have made any analyst calls on TEVA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources